Last Updated: June 13, 2026

AMOXICILLIN - Generic Drug Details

Name: AMOXICILLIN Generic Launch, Drug Patent, and Exclusivity Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for amoxicillin and what is the scope of freedom to operate?

Amoxicillin is the generic ingredient in twenty-five branded drugs marketed by Aurobindo, Chartwell, Hikma Pharms, Labs Atral, Micro Labs, Mylan, Sandoz, Strides Pharma Intl, Sun Pharm Inds Ltd, Teva, Glaxosmithkline, Us Antibiotics, Apothecon, Parke Davis, Wyeth Ayerst, Aurobindo Pharma Ltd, Chartwell Rx, Hikma, Ph Health, Pragma, Ranbaxy Labs Ltd, Ani Pharms, Rising, Takeda Pharms Usa, Cumberland, Phathom, Aurobindo Pharma, Cipla, Deva Holding As, Micro Labs Ltd India, Sandoz Inc, Apotex Inc, Teva Pharms Usa, and Talicia Holdings, and is included in one hundred and twenty-six NDAs. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Amoxicillin has eleven patent family members in six countries.

There are forty-six drug master file entries for amoxicillin. Forty suppliers are listed for this compound.

Summary for AMOXICILLIN

International Patents:	11
US Patents:	12
Tradenames:	25
Applicants:	34
NDAs:	126
Drug Master File Entries:	46
Finished Product Suppliers / Packagers:	40
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	680
Patent Applications:	5,199
Drug Prices:	Drug price trends for AMOXICILLIN
Drug Sales Revenues:	Drug sales revenues for AMOXICILLIN
What excipients (inactive ingredients) are in AMOXICILLIN?	AMOXICILLIN excipients list
DailyMed Link:	AMOXICILLIN at DailyMed

See drug prices for AMOXICILLIN

Drug Sales Revenue Trends for AMOXICILLIN

See drug sales revenues for AMOXICILLIN

Recent Clinical Trials for AMOXICILLIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Shandong University of Traditional Chinese Medicine	NA
Kashi Prefecture Hospital of Traditional Chinese Medicine	NA
Yueyue Li	NA

See all AMOXICILLIN clinical trials

Pharmacology for AMOXICILLIN

Drug Class	Penicillin-class Antibacterial

Medical Subject Heading (MeSH) Categories for AMOXICILLIN

Anti-Bacterial Agents

Anatomical Therapeutic Chemical (ATC) Classes for AMOXICILLIN

J01CA	Penicillins with extended spectrum
J01C	BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for AMOXICILLIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Us Antibiotics	AMOXIL	amoxicillin	TABLET;ORAL	050754-002	Jul 10, 1998		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Wyeth Ayerst	WYMOX	amoxicillin	CAPSULE;ORAL	062120-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Aurobindo	AMOXICILLIN	amoxicillin	TABLET;ORAL	065256-001	Nov 9, 2005	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Talicia Holdings	TALICIA	amoxicillin; omeprazole magnesium; rifabutin	CAPSULE, DELAYED RELEASE;ORAL	213004-001	Nov 1, 2019		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for AMOXICILLIN

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pragma	MOXATAG	amoxicillin	TABLET, EXTENDED RELEASE;ORAL	050813-001	Jan 23, 2008	6,544,555	⤷ Start Trial
Pragma	MOXATAG	amoxicillin	TABLET, EXTENDED RELEASE;ORAL	050813-001	Jan 23, 2008	6,723,341	⤷ Start Trial
Pragma	MOXATAG	amoxicillin	TABLET, EXTENDED RELEASE;ORAL	050813-001	Jan 23, 2008	6,669,948	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for AMOXICILLIN

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	2008069806		⤷ Start Trial
Japan	2010511607	変性放出アモキシシリン製剤	⤷ Start Trial
European Patent Office	1969134	PRODUITS D'AMOXICILLINE À LIBÉRATION MODIFIÉE (MODIFIED RELEASE AMOXICILLIN PRODUCTS)	⤷ Start Trial
Japan	5788142		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.